Filtered By:
Condition: Heart Disease
Procedure: Anesthesia
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 184 results found since Jan 2013.
Guideline on carotid surgery for stroke prevention: updates from the Italian Society of Vascular and Endovascular Surgery. A trend towards personalized medicine
CONCLUSIONS: This GL updates on the main recommendations for the most appropriate diagnostic and medical-surgical management of patients with atherosclerotic carotid artery stenosis to prevent ischemic stroke. This GL also provides useful elements for the application of PM in good clinical practice.PMID:35848869 | DOI:10.23736/S0021-9509.22.12368-2
Source: The Journal of Cardiovascular Surgery - July 18, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Gaetano Lanza Massimiliano Orso Giuseppe Alba Sergio Bevilacqua Laura Capoccia Alessandro Cappelli Giampaolo Carrafiello Carlo Cernetti Marina Diomedi Walter Dorigo Gianluca Faggioli Vanni Giannace David Giannandrea Matteo Giannetta Jessica Lanza Gianfran Source Type: research
Preoperative preparation and premedication of bariatric surgical patient
Marina Varbanova, Brittany Maggard, Rainer LenhardtSaudi Journal of Anaesthesia 2022 16(3):287-298
The prevalence of obesity has tripled worldwide over the past four decades. The United States has the highest rates of obesity, with 88% of the population being overweight and 36% obese. The UK has the sixth highest prevalence of obesity. The problem of obesity is not isolated to the developed world and has increasingly become an issue in the developing world as well. Obesity carries an increased risk of many serious diseases and health conditions, including type 2 diabetes, heart disease, stroke, sleep...
Source: Saudi Journal of Anaesthesia - June 20, 2022 Category: Anesthesiology Authors: Marina Varbanova Brittany Maggard Rainer Lenhardt Source Type: research
New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news
Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
RARITAN, N.J., April 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) in reducing severe vascular events in patients with PAD after lower-extremity revascularization (LER), a procedure that restores blood flow to the legs. Data from the two analyses demonstrate the role that the XARELTO® vascular dose plays in PAD patients with and without chronic kidney disease (CKD) and in PAD patients with and ...
Source: Johnson and Johnson - April 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Revised cardiac score index is a predictor of long-term outcomes after carotid endarterectomy
Conclusion: RCRI and CtRCRI did not predict MACE in the perioperative period but are good predictors of 30-day complications (Clavien-Dindo ≥2). Both RCRI and CtRCRI have good prognostic value as predictors of long-term cardiovascular events.PMID:35171024 | DOI:10.1024/0301-1526/a000988
Source: VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases - February 16, 2022 Category: Surgery Authors: Filipa J ácome Leandro N óbrega Ant ónio Pereira-Neves Lu ís Duarte-Gamas Joana Mour ão Pedro Videira-Reis Marina Dias-Neto Jo ão Rocha-Neves Source Type: research
